Market capitalization | $11.76b |
Enterprise Value | $19.78b |
P/B ratio (TTM) P/B ratio | 4.10 |
Cash position | $897.00m |
P/E forward | 23.76 |
P/S forward | 1.43 |
EV/Sales forward | 2.41 |
As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.
7 Analysts have issued a Solventum forecast:
7 Analysts have issued a Solventum forecast:
Jun '24 |
+/-
%
|
||
Revenue | 2,081 2,081 |
-
|
|
Gross Profit | 1,137 1,137 |
-
|
|
EBITDA | 377 377 |
-
|
EBIT (Operating Income) EBIT | 244 244 |
-
|
Net Profit | 89 89 |
-
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Solventum Corp. operates as a health care company. The company was founded on January 24, 2023 and is headquartered in Maplewood, MN.
Head office | United States |
CEO | Bryan Hanson |
Employees | 22,000 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.